WWFHTX
@WWFHTX
Followers
388
Following
2K
Media
311
Statuses
5K
WWFHTX is a grassroots initiative that unites health consumers, biopharmaceutical company employees vendors, suppliers, academic and community partners.
Texas
Joined April 2013
The prescription drug supply chain, including #PBMs, is now making more money off of those #medicines than the #biopharma companies that developed them. @txhbi From: Berkeley Research Group #BRG.
thinkbrg.com
Many of the same market dynamics observed in our previous publications have continued and even intensified in recent years.
0
0
1
.@blackdoctor_org urges opposition to #340B PATIENTS Act, which, if passed, could cement in law one of the most misused features of the 340B program – contract pharmacies. #340BReform
blackdoctor.org
340B PATIENTS Act is Against what BlackDoctor.org (BDO) Believes In – Oppose it Join BlackDoctor.org (BDO) as we sound the alarm to oppose the 340B PATIENTS Act, which – if passed – could cement in...
0
0
0
Congressman & former pharmacy owner on the #PBMReform Act: “It’s time to bust up the #PBM monopoly, which has been stealing hope and health from patients for decades.” @TXDisabilities
wjcl.com
Pharmacy Benefit Managers (PBMs) essentially act as intermediaries between drug manufacturers, insurance companies, and pharmacies.
0
0
0
New study shows reforming payments to #PBMs could lower annual U.S. drug spending by nearly $100 billion. #PBM #PBMreform
managedhealthcareexecutive.com
Health policy researcher Geoffrey Joyce argues that only delinking compensation from the list price of a drug will lower drug spending.
0
0
0
Instead of #MostFavoredNation (#MFN) policies, Congress should consider other solutions to lower drug costs, such as increasing transparency in #PBM practices. @txhbi
lohud.com
As leaders across the United States consider options to reduce healthcare costs, they must ensure that well-intended reforms do not produce harm.
0
6
7
Breaking the link between prescription drug list prices and compensation to middlemen #PBMs could cut a significant portion of the nation’s annual drug tab. #PBMreform @NASWTX
eurekalert.org
Delinking pharmacy middlemen compensation from list prices and shifting to transparent, fair payment models would reduce annual drug spending by nearly $100 billion, a new USC Schaeffer Center...
0
0
0
Learn from @weworkforhealth co-chair why @WhiteHouse #MostFavoredNation policy would only serve to continue to enrich middlemen #PBMs. #PBMreform is needed.
riograndeguardian.com
Excessive markups don’t benefit patients – they simply enrich middlemen, writes the co-chair of the We Work For Health Coalition.
0
0
0
Why @WhiteHouse #MFN drug pricing policy means fewer treatments, longer wait times and fewer cures developed here in the U.S.
captimes.com
Rob Gundermann: Importing foreign price controls means importing their consequences: fewer treatments, longer wait times and fewer cures developed here at home.
0
0
0
Lack of transparency in #PBM pricing practices leads to inflated out-of-pocket costs for patients and forces many to skip prescriptions. More here on the need for #PBMreform. @TXDisabilities
savannahnow.com
In this opinion piece, former Democratic National Committee chairperson Howard Dean urges Democrats in Congress to help lower drug costs.
0
0
0
Per @weworkforhealth co-chair on #MostFavoredNation policy: “Simply importing foreign price controls won’t make our system fairer or more affordable—but #PBMreform will.”
riograndeguardian.com
Excessive markups don’t benefit patients – they simply enrich middlemen, writes the co-chair of the We Work For Health Coalition.
0
0
0
“As a pharmacist, I’ve seen how #PBMs abuse patients firsthand, and believe that the cure to this infectious disease is transparency, competition and accountability, which is exactly what our bipartisan package provides.” @RepBuddyCarter
fiercehealthcare.com
While major pharmacy benefit management reform was stripped out of the Big Beautiful Bill, a bipartisan group of representatives has introduced legislation that takes aim at the industry. | While...
0
0
0
.@WhiteHouse proposed #MostFavoredNation policy will lead to fewer drugs being developed because of drug #pricecontrols. @BioNorthTX
dcjournal.com
Prescription drugs account for 15 percent of healthcare costs. Yet, they’re our best defense against the chronic diseases that drive 90 percent of
0
0
0
Recent @WhiteHouse #MostFavoredNation exec. order could make it harder for millions of Americans to access their life-saving medications. Learn how, here:
myjournalcourier.com
Most Favored Nation pricing would tie U.S. drug prices to those paid in other high-income countries.
0
0
0
Read interview with pharmacist @RepBuddyCarter about 4 key #PBMReform bills that would tackle the questionable tactics of #PBMs. @TXDisabilities
drugtopics.com
Congressman Buddy Carter (R-GA) champions the PBM Reform Act of 2025, aiming to enhance drug price transparency and empower pharmacists in healthcare delivery.
0
0
0
Per @ShopFloorNAM: “Manufacturers commend Rep. Carter for introducing legislation to enact much-needed #PBM reforms, and we encourage Congress to take steps to curtail #PBMs’ abusive practices.” @TXManufacturers
nam.org
The NAM has long called for the comprehensive reform of pharmacy benefit managers, and on Thursday, Rep. Buddy Carter (R-GA) delivered for manufacturers. What’s going on: Rep. Carter, along with a...
0
0
0
Per @weworkforhealth co-chair on #MostFavoredNation policy: “Simply importing foreign price controls won’t make our system fairer or more affordable—but #PBMreform will.”
riograndeguardian.com
Excessive markups don’t benefit patients – they simply enrich middlemen, writes the co-chair of the We Work For Health Coalition.
0
1
0
Why @AMACforAmerica supports the #PBMReform Act to address the tactics of unaccountable middlemen in the drug supply chain – #PBMs. @txhbi
amac.us
AMAC backs the PBM Reform Act to protect seniors from rising drug prices and support fair pharmacy access under Medicare Part D.
0
0
0
RT @weworkforhealth: At a time when university-led innovation is already declining, policies like the #IRA and #MFN are further endangering….
weworkforhealth.org
American innovation has long been the envy of the world, built on a foundation of strong intellectual property protections, public-private collaboration, and world-class research institutions. But...
0
3
0
Learn from @weworkforhealth co-chair why @WhiteHouse #MostFavoredNation policy would only serve to continue to enrich middlemen #PBMs. #PBMreform is needed.
riograndeguardian.com
Excessive markups don’t benefit patients – they simply enrich middlemen, writes the co-chair of the We Work For Health Coalition.
0
0
0
RT @weworkforhealth: A new @_PILMA study shines a light on the tradespeople behind the labs where life-saving medicines begin. With over 1k….
weworkforhealth.org
A common depiction of a U.S. biopharmaceutical industry worker shows someone working alone in a sterile lab environment. They wear a medical-grade mask covering their face and have their hair...
0
3
0
“#340B hospitals ultimately realized they could buy heavily discounted drugs and then resell them to insured, middle-class patients at huge markups. In some cases, hospitals have charged cancer patients nearly ten times what they paid to acquire the drug.”
realclearhealth.com
An obscure, supposedly free federal program is quietly blowing a hole in state budgets -- by depriving state governments of billions in corporate tax revenue and inflating costs for their public empl
0
0
0